New research sheds light on mediators of improved outcomes in dario users

Two new analyses associate improved clinical and economic outcomes with use of dario's digital health solution new york , nov. 21, 2023 /prnewswire/ -- dariohealth corp. (nasdaq: drio) ("dario" or the "company"), a leader in the global digital health market, announced today two new analyses recently presented by sanofi u.s. demonstrating two mediators associated with improved clinical and economic in dario users. improved clinical outcomes linked with improved medication adherence presentations by sanofi u.s. at the diabetes technology society (dts) annual conference, held nov. 2 – 4, examined real-world data from matched dario users and non-users with type 2 diabetes to determine the association of medication adherence from dario's digital health solution with blood glucose control.
DRIO Ratings Summary
DRIO Quant Ranking